Combining MK626, a Novel DPP-4 Inhibitor, and Low-Dose Monoclonal CD3 Antibody for Stable Remission of New-Onset Diabetes in Mice
Crossref DOI link: https://doi.org/10.1371/journal.pone.0107935
Published Online: 2014-09-30
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Ding, Lei
Gysemans, Conny A.
Stangé, Geert
Heremans, Yves
Yuchi, Yixing
Takiishi, Tatiana
Korf, Hannelie
Chintinne, Marie
Carr, Richard D.
Heimberg, Harry
Pipeleers, Daniel
Mathieu, Chantal
License valid from 2014-09-30